CN Patent

CN102015682B — 作为肾素抑制剂的3,4-取代的哌啶衍生物

Assigned to Actelion Pharmaceuticals Ltd · Expires 2014-07-16 · 12y expired

What this patent protects

本发明涉及基于3，4-取代的哌啶基的肾素抑制剂化合物，在4位携带了氧代吡啶并且具有式(I)。本发明进一步包含所述化合物的药学组合物，以及它们在治疗心血管事件和肾机能不全中的用途。

USPTO Abstract

本发明涉及基于3，4-取代的哌啶基的肾素抑制剂化合物，在4位携带了氧代吡啶并且具有式(I)。本发明进一步包含所述化合物的药学组合物，以及它们在治疗心血管事件和肾机能不全中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102015682B
Jurisdiction
CN
Classification
—
Expires
2014-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.